Erasmus Biomedical Fund

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2011	argenx	$37.1M Series B	Michael B. Sheffery, Isabelle de Cremoux	BioGeneration Ventures, Credit Agricole Private Equity, Forbion, LSP, Thuja Capital, VIB

Total Raised

N/A

Valuation

N/A